Clinical utility of naloxegol in the treatment of opioid-induced constipation.

Author: AtayeeRabia S, BrunerHeather C, BuckholzGary T, EdmondsKyle P

Paper Details 
Original Abstract of the Article :
Opioids are a class of medications frequently used for the treatment of acute and chronic pain, exerting their desired effects at central opioid receptors. Agonism at peripherally located opioid receptors, however, leads to opioid-induced constipation (OIC), one of the most frequent and debilitating...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472065/

データ提供:米国国立医学図書館(NLM)

Naloxegol: A New Treatment Option for Opioid-Induced Constipation

This research explores the complex and often challenging issue of opioid-induced constipation (OIC), focusing on the therapeutic potential of naloxegol, a peripherally acting mu-opioid receptor antagonist (PAMORA). The study provides a comprehensive review of naloxegol's clinical utility in managing OIC in noncancer patients. The researchers discovered that naloxegol was effective in relieving OIC in patients who failed traditional constipation treatments. This finding suggests that naloxegol may offer a promising new option for treating OIC, but further research is needed to establish its role in primary prevention.

Addressing the Side Effects of Opioids

This research highlights the importance of addressing the often-overlooked side effects of opioid therapy. The study's findings indicate that naloxegol may offer a valuable tool for managing OIC, a common and debilitating side effect of opioid use. This research underscores the importance of developing effective strategies to manage the side effects of opioid therapy while maximizing its therapeutic benefits.

Navigating the Complexities of Pain Management

Managing pain can be a complex journey, and navigating the side effects of opioid therapy can be a challenging aspect. This study offers valuable insights into the potential of a new medication, naloxegol, for treating OIC. It's a reminder that a comprehensive approach to pain management includes addressing potential side effects and finding solutions to improve patient outcomes.

Dr.Camel's Conclusion

This study provides a comprehensive review of naloxegol, a PAMORA, for the treatment of OIC in noncancer patients. The study's findings indicate that naloxegol may offer a promising new option for treating OIC, but further research is needed to establish its role in primary prevention. This research highlights the importance of addressing the often-overlooked side effects of opioid therapy and developing effective strategies to improve patient outcomes.

Date :
  1. Date Completed 2015-06-25
  2. Date Revised 2020-09-30
Further Info :

Pubmed ID

26109876

DOI: Digital Object Identifier

PMC4472065

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.